Medications for Aidsrelated Kaposi Sarcoma

7 results

  • Doxorubicin hydrochloride liposome (doxorubicin hydrochloride liposome)

    (Doxorubicin Hydrochloride Liposome)
    Baxter Healthcare Corporation
    Usage: Doxorubicin hydrochloride liposome injection is indicated for treating advanced ovarian cancer after platinum therapy failure, AIDS-related Kaposi’s sarcoma post-chemotherapy failure or intolerance, and multiple myeloma in combination with bortezomib in patients having received prior therapy.

  • Paclitaxel (paclitaxel)

    (paclitaxel)
    Gland Pharma Limited
    Usage: Paclitaxel Injection, USP is indicated for treating advanced ovarian carcinoma, node-positive breast cancer after doxorubicin, metastatic breast cancer post-chemotherapy, nonsmall cell lung cancer in inoperable patients, and second-line treatment of AIDS-related Kaposi’s sarcoma. It can be used in combination with cisplatin for specific conditions.

  • Paclitaxel (paclitaxel)

    (Paclitaxel)
    Natco Pharma USA LLC
    Usage: Paclitaxel Injection, USP is indicated for advanced ovarian carcinoma, adjuvant treatment of node-positive breast cancer, breast cancer after prior chemotherapy failure, first-line treatment of non-small cell lung cancer, and second-line treatment of AIDS-related Kaposi’s sarcoma.

  • Paclitaxel (paclitaxel)

    (Paclitaxel)
    Alembic Pharmaceuticals Limited
    Usage: Paclitaxel Injection, USP, is indicated for the treatment of advanced ovarian carcinoma, node-positive breast cancer (adjuvant), breast cancer post-chemotherapy failure, non-small cell lung cancer (first-line inoperable cases), and second-line treatment of AIDS-related Kaposi's sarcoma.

  • Paclitaxel (paclitaxel)

    (Paclitaxel)
    Novadoz Pharmaceuticals LLC
    Usage: Paclitaxel Injection, USP is indicated for advanced ovarian carcinoma, adjuvant node-positive breast cancer, metastatic breast cancer after chemotherapy failure, first-line treatment of non-small cell lung cancer, and second-line treatment of AIDS-related Kaposi's sarcoma. It is often used in combination with cisplatin for specific indications.

  • Paclitaxel (paclitaxel)

    (Paclitaxel)
    Alembic Pharmaceuticals Inc.
    Usage: Paclitaxel Injection, USP is indicated for treating advanced ovarian carcinoma, adjuvant node-positive breast cancer, breast cancer post-chemotherapy failure, non-small cell lung cancer (with cisplatin), and as second-line therapy for AIDS-related Kaposi's sarcoma.

  • Panretin® (alitretinoin)

    (alitretinoin)
    Ligand Pharmaceuticals Incorporated
    Usage: Panretin® gel is indicated for topical treatment of cutaneous lesions in patients with AIDS-related Kaposi’s sarcoma. It is not suitable for cases requiring systemic therapy, such as significant new lesions or symptomatic involvement.